Failure of Immunotherapy in Alzheimer’s Clinical Trials May Be Due to Presence of Another Form of Dementia – Alzheimer’s News Today


Alzheimer's News Today

Failure of Immunotherapy in Alzheimer's Clinical Trials May Be Due to Presence of Another Form of Dementia
Alzheimer's News Today
VCID is the second most common form of dementia behind Alzheimer's disease, and it is estimated that 40 percent of Alzheimer's patients also have some form of VCID. The main hallmark of Alzheimer's disease is the accumulation of aggregates of the Aβ ...